Microcystic meningioma

• Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis
• Neuroradiological Evaluation of Anatomo-Morphometric Arcuate Fascicle Modifications According to Different Brain Tumor Histotypes: An Italian Multicentric Study
• Posterior parasagittal meningiomas display aggressive features independent of size: a multicenter analysis
• The role of nuclear medicine in central nervous system evaluation
• Advancing Neurosurgical Oncology and AI Innovations in Latin American Brain Cancer Care: Insights from a Center of Excellence
• Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas
• Comparative analysis of transformer-based deep learning models for glioma and meningioma classification
• Investigation of the frequency of meningothelial hyperplasia and its clinicopathological correlation in patients diagnosed with subdural hematoma

Microcystic Meningioma is a recognized meningioma histological subtype, classified by the WHO as typically Grade 1 (benign).

Definition: A variant of meningioma characterized by abundant small cystic spaces (microcysts) between tumor cells.

Symptoms depend on tumor location (e.g., headaches, seizures, focal neurological deficits).

Growth is usually slow.

Microcystic meningioma diagnosis.

Very good, since it is usually a benign lesion (WHO Grade 1).

Surgical resection is often curative.